Abstract: It is an object of the present invention to provide a method for producing gold colloid having a targeted particle size, a sharp particle size distribution and a uniform and perfect spherical shape. The present invention relates to a method for producing gold colloid including a nucleation step of forming nuclear colloidal particles by adding a first reducing agent to a first gold salt solution; and a growth step of growing nuclear colloid by adding a second gold salt and a second reducing agent to the solution of the nuclear colloidal particles, characterized in that the growth step is performed at least once; a citrate is used as the first reducing agent and an ascorbate is used as the second reducing agent; and the addition of the ascorbate in the growth step is performed simultaneously with addition of the second gold salt.
Type:
Application
Filed:
May 29, 2007
Publication date:
June 24, 2010
Inventors:
Junichi Taniuchi, Hirofumi Nakagawa, Koji Okamoto
Abstract: Disclosed are thermotherapeutic compositions for treating disease material, and methods of targeted therapy utilizing such compositions. These compositions comprise a) stable single domain magnetic particles; b) magnetic nanoparticles comprising aggregates of superparamagnetic grains; or c) magnetic nanoparticles comprising aggregates of stable single magnetic domain crystals and superparamagnetic grains. These compositions may also comprise a radio isotope, potential radioactive isotope, chemotherapeutic agent. These methods comprise the administration to a patient's body, body part, body fluid, or tissue of bioprobes (energy susceptive materials attached to a target-specific ligand), and the application of energy to the bioprobes so as to destroy, rupture, or inactivate the target in the patient. Energy forms, such as AMF, are utilized to provide the energy.
Abstract: The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present invention include a carrier, where the carrier is formed from a combination of a triglyceride and at least two surfactants, at least one of which is hydrophilic. Upon dilution with an aqueous medium, the carrier forms a clear, aqueous dispersion of the triglyceride and surfactants.
Type:
Application
Filed:
November 24, 2009
Publication date:
June 3, 2010
Applicant:
LIPOCINE, INC.
Inventors:
FENG-JING CHEN, MAHESH V. PATEL, DAVID T. FIKSTAD, HUIPING ZHANG, CHANDRASHEKAR GILIYAR
Abstract: Use of physical vapor deposition methodologies to deposit nanoscale gold on activating support media makes the use of catalytically active gold dramatically easier and opens the door to significant improvements associated with developing, making, and using gold-based, catalytic systems. The present invention, therefore, relates to novel features, ingredients, and formulations of gold-based, heterogeneous catalyst systems generally comprising nanoscale gold deposited onto a nanoporous support.
Type:
Grant
Filed:
September 23, 2004
Date of Patent:
June 1, 2010
Assignee:
3M Innovative Properties Company
Inventors:
Larry A. Brey, Thomas E. Wood, Gina M. Buccellato, Marvin E. Jones, Craig S. Chamberlain, Allen R. Siedle
Abstract: The present invention relates to a rapid immunochromatographic test device suitable to detect more than one target in a single assay at the same time, uses of said device for detecting diseases in a sample, a method for the production of said device as well as a kit comprising the device.
Type:
Application
Filed:
December 6, 2007
Publication date:
May 13, 2010
Inventors:
Adnan Badwan, Murshed Abdel-Qader Mohammed
Abstract: In a method of forming a light emissive nanostructure, a quantum dot is provided and a crosslinked-glutathione layer around the quantum dot is formed. The light emissive nanostructure thus comprises a quantum dot and a crosslinked-glutathione layer around the quantum dot. In another method, a metal-based nanostructure is provided, and a crosslinked-glutathione layer coated on a surface of the metal-based nanostructure is formed. The metal-based nanostructure is thus coated with a crosslinked-glutathione layer. To promote crosslinking and stability, the glutathione layer may be crosslinked in the presence of an activating agent and sufficient amount of free glutathione.
Abstract: Semiconductor quantum dots are becoming valuable analytical tools for use in biomedical applications. Indeed, their unique properties offer the opportunity to design luminescent probes for imaging and sensing with unprecedented performance. In this context, we have identified operating principles to transduce supramolecular association of complementary receptor-ligand binding pairs into enhancement or suppression in the luminescence of sensitive quantum dots. Thus, complementary receptor-ligand binding pairs can be identified with luminescence measurements relying on our design logic. In fact, we have demonstrated with a representative example that our protocol can be adapted to signal receptor-ligand binding.
Type:
Application
Filed:
July 9, 2007
Publication date:
May 6, 2010
Inventors:
Francisco M. Raymo, Massimilliano Tomasulo, Ibrahim Yildiz
Abstract: The invention relates to a method for preparing an aqueous suspension of carbon nanotubes, that comprises: contacting in an aqueous medium said nanotubes with at least one dispersant comprising a copolymer including at least one anionic hydrophile monomer and at least one monomer containing at least one aromatic group substituted by at least one chain containing one or more oxygen atoms, said chain linking the aromatic group to the unsaturated or cyclic chain of the monomer capable of opening during the formation of the copolymer, the weight ratio between the dispersant and the carbon nanotubes ranging from 0.6:1 to 1.9:1; and mechanically processing the mixture thus obtained using ultrasounds or a rotor-stator system or by passing it in a bead or ball grinder, the invention also relates to the suspension thus obtained and to the uses thereof.
Abstract: The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 1 to about 20 weight percent of a vinca alkaloid; and about 50 to about 99 weight percent biocompatible polymer.
Type:
Application
Filed:
June 16, 2009
Publication date:
April 29, 2010
Inventors:
Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
Abstract: A method for providing nanoparticle clusters of controlled dimensions is described. The method involves an activation of individual nanoparticles and the subsequent interaction between activated particles to form a cluster.
Abstract: A lead includes a lead body extending from a lead proximal end portion to a lead distal end portion and having an intermediate portion therebetween, one or more tissue sensing/stimulation electrodes disposed along the lead body, one or more terminal connections disposed along the lead proximal end portion. The lead further includes one or more conductors contained within the lead body extending between the tissue sensing/stimulation electrodes and the terminal connections, and a fibrous matrix coating is disposed onto at least a portion of the lead body and/or sensing/stimulation electrodes.
Type:
Grant
Filed:
May 1, 2006
Date of Patent:
March 30, 2010
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Jeannette C. Polkinghorne, Xiangchun Jiang, Daniel J. Cooke
Abstract: The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
Type:
Application
Filed:
June 16, 2009
Publication date:
March 18, 2010
Inventors:
Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
Abstract: A sensor apparatus comprising a nanotube or nanowire, a lipid bilayer around the nanotube or nanowire, and a sensing element connected to the lipid bilayer. Also a biosensor apparatus comprising a gate electrode; a source electrode; a drain electrode; a nanotube or nanowire operatively connected to the gate electrode, the source electrode, and the drain electrode; a lipid bilayer around the nanotube or nanowire, and a sensing element connected to the lipid bilayer.
Type:
Application
Filed:
February 10, 2009
Publication date:
March 18, 2010
Inventors:
Aleksandr Noy, Olgica Bakajin, Sonia Letant, Michael Stadermann, Alexander B. Artyukhin
Abstract: The present disclosure generally relates to methods of making nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol.
Type:
Application
Filed:
June 16, 2009
Publication date:
March 18, 2010
Inventors:
Greg Troiano, Michael Figa, Abhimanyu Sabnis
Abstract: A nanoparticle of glucidamin derived from organism for treating tumor and preparation method thereof, wherein the viscosity-average molecular weight of glucidamin is in the range of 1×103-9×105, and the amount of free amino groups in the glucidamin is in the range of 50%-100% based on the total amino groups. The preparation method of the nanoparticle comprises steps listed below: (1) adding the glucidamin possessing one or more molecular weight into thin acid solution at 20-60° C. to form saccharan solution, wherein the content of saccharan in solution is in the range of 0.1%-5% by weight; (2) adjusting the pH of the solution to 6-9 in order to form emulsion of microparticle; (3) separating the microparticle from the emulsion, dried at low temperature to obtain the nanoparticle of glucidamin for treating tumor. The nano-class glucidamin can enhance their activity against tumor.
Abstract: Carrier nanoparticles comprising a polymer containing a polyol coupled to a polymer containing a boronic acid, configured to present the polymer containing a boronic acid to an environment external to the nanoparticle and related compositions, methods and systems.
Abstract: Provided are the preparation, characterization, and application of a nanopore membrane device. The nanopore device comprises a thin membrane prepared from glass, fused silica, ceramics or quartz, containing one or more nanopores ranging from about 2 nm to about 500 nm. The nanopore is prepared by a template method using sharpened metal wires and the size of the pore opening can be controlled during fabrication by an electrical feedback circuit. The nanopore device is particularly useful for counting and analyzing nanoparticles of radius less than 400 nm.
Type:
Application
Filed:
May 2, 2007
Publication date:
February 4, 2010
Applicant:
UNIVERSITY OF UTAH RESEARCH FOUNDATION
Inventors:
Henry S. White, Bo Zhang, Ryan J. White, Eric N. Ervin
Abstract: The present invention includes composition, methods of making and methods of using a multi-nano-well plate having a first layer at least partially disposed on the substrate and one or more nano-wells that extends through the first layer that extends toward the substrate, wherein the one or more nano-wells having an opening in the first layer connected to bottom layer by one or more walls.
Type:
Application
Filed:
July 24, 2009
Publication date:
January 28, 2010
Applicant:
Life BioScience, Inc.
Inventors:
Jeb H. Flemming, Colin T. Buckley, Blake Ridgeway
Abstract: Electrical devices comprised of nanowires are described, along with methods of their manufacture and use. The nanowires can be nanotubes and nanowires. The surface of the nanowires may be selectively functionalized. Nanodetector devices are described.
Type:
Application
Filed:
September 30, 2009
Publication date:
January 28, 2010
Applicant:
President and Fellows of Harvard College
Inventors:
Charles M. Lieber, Hongkun Park, Qingqiao Wei, Yi Cui, Wenjie Liang
Abstract: The present invention provides a device and methods of use thereof in concentrating a species of interest and/or controlling liquid flow in a device. The methods, inter-alia, make use of a device comprising microchannels, which are linked to nanochannels, whereby induction of an electric field in the nanochannel results in ion depletion in the linkage region between the microchannel and nanochannel, and a space charge layer is formed within the microchannel, which provides an energy barrier for said species of interest which enables its concentration in a region in the microchannel.
Abstract: An aromatic hydrocarbon solution of a fullerene or a fullerene mixture is mixed with an ethanol solution of polyvinylpyrrolidone (PVP), water is added to the mixed solution, the solvent is removed and then an aqueous solution of a complex of a fullerene or a fullerene mixture with polyvinylpyrrolidone (PVP) is obtained. Under a condition free from a halogen, a PVP/fullerene complex excellent in manifestation of fullerene properties, stability and safety and an aqueous solution thereof are obtained.
Abstract: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.
Type:
Application
Filed:
April 3, 2009
Publication date:
January 21, 2010
Applicants:
Duke University, Immunolight, LLC
Inventors:
Frederic J. BOURKE, JR., Tuan Vo-Dinh, Harold Walder
Abstract: Provided is a method for treating cancer using a porous silicon nanobomb. The porous silicon nanobomb can be exploded by NIR light irradiation at a low intensity to selectively destroy cancer cells. Also, porous silicon itself shows good biocompatibility and biodegradability. Thus, the present invention can be used as an efficient method for treating cancer without the accumulation of toxic side effects.
Type:
Application
Filed:
February 27, 2009
Publication date:
December 31, 2009
Applicant:
Inha-Industry Partnership Institute
Inventors:
Chongmu Lee, Hohyeong Kim, Chanseok Hong
Abstract: An apparatus and method for providing hyperthermia treatments in a deposit surrounded by tissue in a body is disclosed. A radio frequency antenna array is used to direct a radio frequency signal at a selected frequency into the deposit so that the radio frequency signal will have a selected wavelength in the deposit to selectively heat the deposit to a temperature greater than the surrounding tissue through resonant heating within the deposit. An injectable medium is injected in the deposit to increase a dielectric value and/or conductivity value of the deposit. The injectable medium is selected to increase a specific absorption rate of the radio frequency signal within the deposit relative to the surrounding tissue.
Abstract: The present invention is related to a nucleic acid molecule comprising a double-stranded structure, whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and said first stretch is at least partially complementary to a target nucleic acid, and whereby the second strand comprises a second stretch of contiguous nucleotides and said second stretch is at least partially complementary to the first stretch, whereby the first stretch comprises a nucleic acid sequence which is at least partially complementary to a nucleotide core sequence of the nucleic acid sequence according to SEQ ID NO:1 (NM_013355), or part thereof, whereby the nucleotide core sequence comprises the nucleotide sequence from nucleotide positions 482 to 500 of SEQ ID NO:1 (SEQ ID NO:2); from nucleotide positions 1555 to 1573 of SEQ ID NO:1 (SEQ ID NO:4); from nucleotide positions 1556 to 1574 of SEQ ID NO:1 (SEQ ID NO:6); from nucleotide posit
Type:
Application
Filed:
July 20, 2007
Publication date:
December 10, 2009
Inventors:
Jorg Kaufmann, Oliver Keil, Ansgar Santel
Abstract: There is described a method of magnetically manipulating a cell in vivo which comprises the association of a magnetizable particle with a cell. More particularly, there is described a method of magnetically manipulating a cell which comprises the association of a magnetizable particle with a cell characterized in that the method comprises agonizing or antagonizing ion channels within a cell by the association of a magnetizable particle with a cell. There is also described the use of a magnetizable particle in a method of magnetically manipulating a cell in vivo and/or activating ion channels in vivo.
Type:
Grant
Filed:
June 19, 2003
Date of Patent:
December 1, 2009
Assignee:
Keele University
Inventors:
Alicia Jennifer Hafeeza El Haj, Jon Paul Dobson
Abstract: The present invention includes methods and devices that detect target molecules in a biological sample. The sample analysis device of the present invention includes nanoparticles. In one embodiment, the nanoparticles are directly immobilized on the surface of the sample analysis device. In another embodiment, the nanoparticles are indirectly immobilized on the surface of the sample analysis device by incorporating them in appropriate media and immobilizing the nanoparticles within a matrix.
Type:
Application
Filed:
May 20, 2009
Publication date:
November 26, 2009
Applicant:
Rapid Pathogen Screening Inc.
Inventors:
Uma Mahesh Babu, Robert W. VanDine, Robert P. Sambursky
Abstract: The invention encompasses a purified preparation of the mitotic spindle matrix essential for mitotic spindle assembly, which allows for identifying an agent that modulates a cell division and/or differentiation signaling pathway comprising determining the effect of the agent on spindle formation, MT nucleation, or lamin matrix assembly wherein the change in spindle formation, MT nucleation or lamin matrix assembly.
Abstract: Conventional blood flow meter can be combined with photonic crystals to measure temperature change for heat washin/washout. These photonic crystals are impregnated into conventional devices as a thermometer. It makes the entire device more compact and easier for patients.
Abstract: A biomolecule detection reagent comprising semiconductor nanoparticles and magnetic nanoparticles, incorporated in a bead comprising an inorganic compound or an organic polymer, and a surface of the beads is modified with a biomolecule detection molecule.
Abstract: A nano-structured device for detecting biological analytes, chemical, analytes, cancer and other physiological conditions, includes a carrier substrate, a transducer film disposed over a surface of the carrier substrate, and a dendrimer structure tethered to the transducer film. The transducer film generates a first signal in response to a mechanical stress applied thereto. The first signal indicates the detection of the biological analyte, chemical analyte, cancer or other physiological condition. The dendrimer structure includes a plurality of receptors for binding the biological analyte, the chemical analyte, or one or more biomarkers indicative of cancer or other physiological conditions to the dendrimer structure.
Type:
Application
Filed:
January 2, 2009
Publication date:
September 3, 2009
Applicant:
LOCKHEED MARTIN CORPORATION
Inventors:
Patricia D. Palena, Richard R. Barto, JR., Tammie L. Borders, Jeffrey A. Stuart
Abstract: This invention relates to high surface area materials, such as nanoparticles, that are coated with metal ions. These modified nanoparticles have active sites that bind various gases and/or odorous compounds, thereby removing these compounds from a medium such as air or water. Metal ions are adsorbed onto the surface of the nanoparticle and bound strongly to the surface. By selection of the metal ion, specific gaseous compounds and/or odorous compounds can be targeted and removed efficiently and effectively from both aqueous phase and from the air. The modified nanoparticles are useful in numerous article of manufacture for industrial and consumer use.
Abstract: This invention provides novel nanofiber enhanced surface area substrates and structures comprising such substrates, as well as methods and uses for such substrates.
Abstract: This disclosure relates to the application of a photoluminescent material with a plurality of nanocrystals, such as quantum dots or Cornell dots, each capable of absorbing electromagnetic energy at a first wavelength and emitting the absorbed energy as a desired wavelength in the direction of a human retina. Preferably, the emitted wavelength is chosen for its ability to suppress naturally occurring melatonin, i.e., blue light. The disclosure also contemplates the placement of the photoluminescent material over the entire surface of a lens or on a portion of the lens to optimize the exposure to the desired wavelength while reducing the overall luminescence. Finally, the photoluminescent material can be applied as a coating, as part of a material applied to the lens, either superficially or in/within the lens, as part of eyewear, or even as an optical treatment system.
Abstract: A chemotherapeutic composition can be configured for subcutaneous administration for preferential intralymphatic accumulation while also providing a therapeutic systemic concentration that is not toxic. The composition can include a pharmaceutically acceptable carrier, and a nanoconjugate configured for preferential intralymphatic accumulation after subcutaneous administration. The nanoconjugate can include a nanocarrier configured for preferential intralymphatic accumulation after subcutaneous or interstitial administration, and a plurality of chemotherapeutic agents coupled to the nanocarrier. The nanoconjugate can have a dimension of about 10 nm to about 50 nm. Also, the nanoconjugate can be loaded with the chemotherapeutic agents from about 10% to about 50% w/w. The nanocarrier can be a hyaluronan polymer of about 3 kDa to about 50 kDa. Alternatively, the nanocarrier can be a dendrimer.
Abstract: The present invention provides methods of using metal nanoparticles 0.5 to 400 nm in diameter to enhance the dose and effectiveness of x-rays or of other kinds of radiation in therapeutic regimes of ablating a target tissue, such as tumor. The metal nanoparticles can be administered intravenously, intra-arterially, or locally to achieve specific loading in and around the target tissue. The metal nanoparticles can also be linked to chemical and/or biochemical moieties which bind specifically to the target tissue. The enhanced radiation methods can also be applied to ablate unwanted tissues or cells ex vivo.
Abstract: The present invention relates to self-assembly of a photosensitizer on a nanoparticle. The invention also provides methods for production of functionalized (eg. stabilized) nanoparticles. The nanoparticles may be used in Photodynamic Therapy (PDT). The invention can provide, for example, self-assembled phthalocyanine monolayers (SAMs), wherein the monolayer is formed on a metallic nanoparticle. The term “metallic” as used herein refers to metals, metal oxides and other metal-containing compositions. According to the invention a functionalized nanoparticle comprises: a metallic core; a photosensitizer monolayer chemically bonded to said core, said monolayer containing molecules capable of photo-excitation to produce a reactive oxygen species such as singlet oxygen, from oxygen molecules; and a phase transfer reagent.
Type:
Grant
Filed:
October 31, 2002
Date of Patent:
July 21, 2009
Assignee:
Cancer Research Technology Limited
Inventors:
David Andrew Russell, Duncan Christopher Hone
Abstract: A method for manufacturing a stabilized metal nano particle solution is disclosed. This method manufactures a metal nano particle solution so as to make a metal substance such as silver, gold, copper, zinc or cobalt into ultra-capsular nano particles. That is to say, this new method is simple and suitable for mass production without requiring any separate reducer putting process at a room temperature while a transition metal nano particle solution is produced. In this method, an alcohol solution including a metal salt solution and a soluble polymer is mixed at a room temperature to make a nano metal particle solution with a particle size of 100 nm or less.
Type:
Application
Filed:
January 9, 2008
Publication date:
July 9, 2009
Inventors:
Dong-Pyo Kim, Yoon-Hyuck Choi, Choong G. Row
Abstract: A biocompatible and biodegradable carbon nanotube-based fiber capable of stimulating and sustaining cell proliferation and stimulating and sustaining nerve regeneration is disclosed herein. The biocompatible and biodegradable carbon nanotube-based fiber comprising at least one carbon nanotube; a biodegradable copolymer; and a coagulating polymer. The present disclosure also relates to a process fro producing such a fiber.
Type:
Application
Filed:
September 18, 2008
Publication date:
July 2, 2009
Inventors:
Stefania Polizu, Philippe Poulin, Oumarou Savadogo, L'Hocine Yahia
Abstract: A woven fabric for an implantable medical device includes a plurality of carbon nanotube strands interwoven with a plurality of textile strands, where each carbon nanotube strand comprises a plurality of carbon nanotubes. An implantable medical device comprises a component and a fabric secured to the component, where the fabric includes a plurality of woven carbon nanotube strands, and each of the carbon nanotube strands comprises a plurality of carbon nanotubes.
Type:
Application
Filed:
September 30, 2008
Publication date:
July 2, 2009
Applicant:
Cook Incorporated
Inventors:
James M. CARLSON, Shyam S.V. Kuppurathanam
Abstract: This invention relates generally to a preparation of bone repair compositions, and more special refers to a novel technology in preparing a matrix building polymer i.e. collagen with inclusions of hydroxyapatite particles as biomaterial for medical applications. In this composition that consists of hydroxyapatite particles embedded in a matrix at least 50% nm. Said composition is suitable as bone implant material, dental cement and for applications in wound healing.
Type:
Application
Filed:
July 21, 2005
Publication date:
June 18, 2009
Applicant:
LISOPHARM AG
Inventors:
Vsevolod Nikolaevich Rudin, Igor Vitallevich Melikhov, Vladimir Vasillevich Minaev, Andrei Yurievich Orlov, Viktor Evgenievich Bozhevolnov
Abstract: The invention provides methods for screening a compound for its effect on endonuclease activity. The methods comprise providing a compound to be screened utilizing a gold nanoparticle aggregate as the substrate for the endonuclease. The gold nanoparticle aggregate is formed by the hybridization of oligonucleotides attached to the nanoparticles, with or without the presence of a third linker oligonucleotide. The hybridized oligonucleotide duplex serves as a substrate for the endonuclease. A detectable change is brought about in the presence of the endonuclease activity. A decrease in the detectable change reflects the reduced levels of endonuclease activities as a result of the effects of endonuclease inhibitors. The present invention also provides kits for screening an endonuclease inhibitor.
Type:
Application
Filed:
January 25, 2008
Publication date:
June 18, 2009
Applicant:
NORTHWESTERN UNIVERSITY
Inventors:
Chad A. Mirkin, Xiaoyang Xu, Min Su Han
Abstract: Sensor platforms and methods of making them are described. A platform having a non-horizontally oriented sensor element comprising one or more nanostructures such as nanotubes is described. Under certain embodiments, a sensor element has or is made to have an affinity for an analyte. Under certain embodiments, such a sensor element comprises one or more pristine nanotubes. Under certain embodiments, the sensor element comprises derivatized or functionalized nanotubes. Under certain embodiments, a sensor is made by providing a support structure; providing one or more nanotubes on the structure to provide material for a sensor element; and providing circuitry to electrically sense the sensor element's electrical characterization. Under certain embodiments, the sensor element comprises pre-derivatized or pre-functionalized nanotubes. Under other embodiments, sensor material is derivatized or functionalized after provision on the structure or after patterning.
Type:
Grant
Filed:
January 17, 2006
Date of Patent:
May 26, 2009
Assignee:
Nantero, Inc.
Inventors:
Brent M. Segal, Thomas Rueckes, Bernhard Vogeli, Darren K. Brock, Venkatachalam C. Jaiprakash, Claude L. Bertin
Abstract: The presently claimed and disclosed inventions relate, in general, to methods of radiation dosimetry and imaging using scintillation luminescence. More particularly, materials having a scintillation luminescence response to radiation that varies with total radiation dose received can be used for dosimetry monitoring, including, but not limited to nanoparticles for in vivo, real-time dosimetry. Energy-transfer nanocomposite materials as well as methods of making and using such materials in various applications including, but not limited to, in vivo radiation dosimetry and imaging, are disclosed. More particularly, the presently claimed and disclosed inventions relate to nanoparticle scintillation luminescence particles encapsulated in hosts of the general formula BaFX and BaFX:Eu2+ where X=Cl, Br and I.
Type:
Grant
Filed:
October 28, 2005
Date of Patent:
May 26, 2009
Assignee:
Nomadics, Inc.
Inventors:
Wei Chen, Shaopeng Wang, Sarah Westcott, Jun Zhang
Abstract: This invention relates generally to biosensor technology, and pertains more particularly to novel multifunctional biosensors based on ordered arrays of metallic, semiconductors and magnetic nano-islands for medical, biological, biochemical, chemical and environmental applications.
Type:
Application
Filed:
June 6, 2006
Publication date:
May 21, 2009
Applicant:
GILUPI GMBH
Inventors:
Ulrich Pison, Michael Giersig, Alex Schaefer
Abstract: A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid.
Abstract: A method of carrying out an autologous tissue implant in a subject in need thereof is carried out by: (a) forming an autologous tissue implant from autologous cells collected from a subject (e.g., by ink-jet printing, the autologous cells and the scaffold, separately or together), and then (b) implanting the autologous tissue implant in said subject.
Type:
Application
Filed:
October 14, 2008
Publication date:
May 7, 2009
Applicants:
Wake Forest University, Wake Forest University Health Sciences
Inventors:
David Carroll, William Wagner, Nicole Levi, Louis Argenta, Michael Morykwas
Abstract: The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from soy or lentil plant material or a reactive extract thereof of the plant material. The gold nanoparticles of the invention can be fabricated with an environmentally friendly method for making biocompatible stabilized gold nanoparticles. In methods of the invention, an aqueous solution containing gold salts is mixed with soy or lentil plant material or a reactive extract thereof. In preferred embodiment methods of making, an aqueous solution containing gold salts is provided. The aqueous solution is mixed with soy or lentil plant material or a reactive extract thereof. The gold salts react to form biocompatible gold nanoparticles that are stabilized with a robust coating derived of the soy or lentil plant material or a reactive extract thereof.
Type:
Application
Filed:
September 30, 2008
Publication date:
May 7, 2009
Applicant:
THE CURATORS OF THE UNIVERSITY OF MISSOURI
Inventors:
Kattesh V. Katti, Raghuraman Kannan, Kavita K. Katti, Nripen Chandra, Ravi Shukla
Abstract: Spontaneous respiration is detected by sensors. An additional amount of oxygen is administered to the lungs via a jet gas current at the end of an inhalation procedure. Breathing volume, absorption of oxygen during inhalation, and clearance of carbon dioxide during exhalation are improved. If required, the exhalation procedure of the patient can be arrested or slowed by a countercurrent to avoid a collapse of the respiration paths. An apparatus including an oxygen pump can be connected to an oxygen source and includes a tracheal prosthesis that can be connected via a catheter. The respiration detections sensors are connected to a control unit for activating the oxygen pump. The tracheal prosthesis includes a tubular support body with a connection for the catheter, and the sensors are associated with the support body. The tracheal prosthesis and jet catheter are dimensioned so the patient can freely breathe and speak without restriction.
Type:
Application
Filed:
September 20, 2006
Publication date:
April 30, 2009
Inventors:
Lutz Freitag, Gregory Kapust, Anthony Wondka
Abstract: According to an aspect of the present invention, medical devices are provided which comprise (a) a substrate having first and second surfaces, (b) a nanofiber-textured layer comprising nanofibers disposed over at least the first surface of the substrate and defining a nanotextured outer surface for the device, and (c) a therapeutic-agent-eluting layer comprising a therapeutic agent and a polymer disposed over at least the second surface of the substrate.